Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Zoccali, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zoccali, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2000) 15: 1919-1921
© 2000 European Renal Association-European Dialysis and Transplant Association


Editorial Comments

Sleep apnoea and nocturnal hypoxaemia in dialysis patients: mere risk-indicators or causal factors for cardiovascular disease?

Carmine Zoccali

CNR Centro Fisiologia Clinica and Divisione di Nefrologia Ospedali Riuniti, Reggio Cal, Italy

Epidemiology of sleep apnoea in the general population and in dialysis patients

Estimates of the prevalence of sleep apnoea syndrome (SA) in the general population give widely different figures, ranging from 0.3 to 8.5% [1–3]. This is probably because of differences in definitions, in the design of the studies and the investigations performed as well as in the age, sex and other characteristics of the populations surveyed. The prevalence of this disturbance in patients on chronic dialysis is still uncertain but available estimates indicate that it may be at least five times higher than that in the general population [4–8]. Snoring is the symptom that usually alerts the physician to suspect SA. Restless sleep, frequent arousal, daytime somnolence, headaches and fatigue are all common complaints of patients with SA which may be mistakenly attributed to chronic renal failure. Perhaps the main reason why SA . . . [Full Text of this Article]

Why is SA so frequent in dialysis patients?

SA and cardiovascular risk in renal failure

Why are SA and nocturnal hypoxaemia in dialysis patients so often overlooked?

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
I. Chakravorty, M. Shastry, and K. Farrington
Sleep apnoea in end-stage renal disease: a short review of mechanisms and potential benefit from its treatment
Nephrol. Dial. Transplant., January 1, 2007; 22(1): 28 - 31.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. Zoccali, F. Mallamaci, and G. Tripepi
Nocturnal Hypoxemia Predicts Incident Cardiovascular Complications in Dialysis Patients
J. Am. Soc. Nephrol., March 1, 2002; 13(3): 729 - 733.
[Abstract] [Full Text] [PDF]